Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form
As of April 1st VIVO Scientific Profiles will no longer updated for faculty, and the link to VIVO will be removed from the library website. Faculty profile pages will continue to be updated via Interfolio. VIVO will continue being used behind the scenes to update graduate student profiles. Please contact helplib@scripps.edu if you have questions.
How to download citations from VIVO | Alternative profile options

Protection of nude mice by passive immunization with a type-common human recombinant monoclonal antibody against hsv

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Sanna, Pietro
  • deLogu, A.
  • Williamson, R. A.
  • Hom, Y. L.
  • Straus, S. E.
  • Bloom, Floyd
  • Burton, Dennis

publication date

  • January 1996

journal

  • Virology  Journal

abstract

  • Herpes simplex viral disease is an important cause of morbidity and mortality in man. Although the development of very effective nucleoside analogs with a high therapeutic index has greatly improved the clinical management of herpetic infections, the emergence of drug-resistant viral strains has become a cause of serious concern both because of its clinical implications and in terms of viral ecology. The present report is the first demonstration of the in vivo protective activity of a type-common human recombinant monoclonal antibody derived from a combinatorial antibody library. Athymic nude mice were infected with HSV type 1 either intracutaneously in the flank or by corneal scarification. Beside reducing morality rates when administered before infection, the antibody dramatically and significantly prolonged survival times (P < 0.0001) when administered up to 24 hr postinfection, a time when the virus had already reached the peripheral nervous system. This suggests that the antibody may act, at least in part, by interfering with axonal transport of the virus and/or with viral expression. These results indicate that human recombinant antibodies isolated by antigen selection from combinatorial libraries can be effective in vivo. Such antibodies could complement antiviral chemotherapy and represent valuable tools for the prophylaxis of infections by the herpes simplex viruses.

subject areas

  • Animals
  • Antibodies, Monoclonal
  • Antibodies, Viral
  • CHO Cells
  • Cercopithecus aethiops
  • Cricetinae
  • Disease Models, Animal
  • Female
  • Herpes Simplex
  • Herpesvirus 1, Human
  • Humans
  • Immunization, Passive
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Recombinant Fusion Proteins
  • Vero Cells
  • Viral Envelope Proteins
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0042-6822

Digital Object Identifier (DOI)

  • 10.1006/viro.1996.0011

PubMed ID

  • 8553581
scroll to property group menus

Additional Document Info

start page

  • 101

end page

  • 106

volume

  • 215

issue

  • 1

©2022 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support